胸腔内纤维溶解疗法用于胸腔感染:从队列研究的结果
Glenn Khai Wern Yong1, Jonathan Jia Jun Wong1, Xiaoe Zhang2
1Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore.
Annals of the Academy of Medicine, Singapore
|January 3, 2025
概括
用阿尔特普拉斯进行的腹腔内纤维解药疗法 (IPFT) 对腹腔感染有效. 早期治疗和较年轻的患者年龄提高了成功率,即使在较低的阿尔特等剂量.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
背景情况:
- 胸腔感染带来了显著的死亡风险.
- 使用alteplase和dornase的脑内纤维解药疗法 (IPFT) 提供了一个非手术治疗选择.
- 在亚洲人群中,最佳的阿尔特普拉斯剂量和成功因素需要澄清.
研究的目的:
- 确定影响新加坡Tan Tock Seng医院IPFT治疗的肺部感染治疗成功的因素.
- 为了评估IPFT中较低剂量的阿尔特等的疗效.
- 分析亚洲患者队列中的治疗结果.
主要方法:
- 用IPFT治疗的131名肺部感染患者的回顾性分析 (2016年7月 - 2023年11月).
- 治疗成功被定义为3个月后没有手术的生存率.
- 统计分析包括线性混合效应模型和后勤回归,考虑人口统计,并发病,RAPID分数和放射性特征.
主要成果:
- 整体治疗成功率为85.5% (112/131例).
- 不同剂量的阿尔泰拉斯在放射性清除中没有显著差异.
- 患者年龄 (OR 0.94) 和从胸管插入到首次IPFT剂量 (OR 0.95) 的时间是治疗成功的重要预测因素.
结论:
- 较低的阿尔特普拉斯起始剂量对于治疗多叶膜感染是有效的.
- 早些时候启动IPFT可能会改善患者的治疗结果.
- 年龄和及时开始治疗是IPFT成功的关键因素.
相关概念视频
01:28Pleural Effusion II: Symptoms and Management
133
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
133
01:26Flail Chest-II
132
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
132
01:27Pneumothorax-II
104
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
104
01:28Pneumonia IV: Management
260
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
260
01:30Pneumonia III: Complications and Assessment
113
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
113
01:13Pleura of the Lungs
1.3K
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
1.3K